CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA) after surgery for colon...
Phase 2, Phase 3
Birmingham, Alabama, United States and 843 other locations
This study will evaluate the safety, tolerability, drug levels, molecular effects, and clinical activity of MRTX849 (adagrasib) in patients with adva...
Phase 1, Phase 2
Birmingham, Alabama, United States and 112 other locations
Study CA239-0006 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab ver...
Phase 3
Birmingham, Alabama, United States and 282 other locations
is to investigate treatment with nivolumab in combination with trametinib with or without ipilimumab in participants with previously treated cancer...
Phase 1, Phase 2
Birmingham, Alabama, United States and 46 other locations
a three-year event rate of adenomas and second primary colorectal cancers in patients previously treated for Stages 0 through III colon...
Phase 3
Birmingham, Alabama, United States and 989 other locations
without biological agent and monalizumab (IPH2201) with biological agent administered to participants with recurrent or metastatic colorectal cancer...
Phase 1, Phase 2
Birmingham, Alabama, United States and 48 other locations
Clinical trials
Research sites
Resources
Legal